Zoetis Inc.

ZTS

$143.93

Name : Zoetis Inc.

Sector : Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Mark. Cap: $63,787,397,120.00

EPSttm : 5.81

Zoetis Inc.

$143.93

0.81%

$1.16

Float Short %

2.08

Margin Of Safety %

Put/Call OI Ratio

1.06

EPS Next Q Diff

-0.13

EPS Last/This Y

0.44

EPS This/Next Y

0.52

Price

142.84

Target Price

194.21

Analyst Recom

1.57

Performance Q

-9.79

Relative Volume

0.89

Beta

0.9

Ticker: ZTS

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-08	ZTS	151.79	1.10	0.78	43037
2025-09-09	ZTS	149.77	1.10	1.55	43450
2025-09-10	ZTS	149.4	1.11	1.20	43545
2025-09-11	ZTS	150.6	1.11	0.03	43680
2025-09-12	ZTS	148.23	0.99	0.50	46024
2025-09-15	ZTS	146.28	0.99	1.02	46339
2025-09-16	ZTS	147.46	0.98	1.04	48541
2025-09-17	ZTS	146.93	0.98499512036435	41.363302752294	48815
2025-09-18	ZTS	147.14	1.31	0.98	56784
2025-09-22	ZTS	144.61	1.21	0.27	44507
2025-09-23	ZTS	142.6	1.16	0.40	45893
2025-09-24	ZTS	141.72	1.12	0.88	46222
2025-09-25	ZTS	141.14	1.11	0.52	46844
2025-09-26	ZTS	143.53	1.06	1.40	48223
2025-09-29	ZTS	143.05	1.07	5.05	50381
2025-09-30	ZTS	146.24	1.06	0.53	51340
2025-10-01	ZTS	146.98	1.04	0.54	52368
2025-10-02	ZTS	146.52	1.05	1.06	52708
2025-10-03	ZTS	146.45	1.05	2.14	53247
2025-10-06	ZTS	145.38	1.06	0.49	53783
2025-10-07	ZTS	142.78	1.06	1.98	54094
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-08	ZTS	151.75	3.9	187.6	6.33
2025-09-09	ZTS	149.77	3.9	177.9	6.33
2025-09-10	ZTS	149.43	3.9	214.9	6.33
2025-09-11	ZTS	150.61	3.9	250.9	6.33
2025-09-12	ZTS	148.19	3.9	167.4	6.33
2025-09-15	ZTS	146.27	3.9	178.0	6.34
2025-09-16	ZTS	147.46	3.9	251.9	6.35
2025-09-17	ZTS	146.88	3.9	209.6	6.35
2025-09-18	ZTS	147.09	3.9	227.0	6.35
2025-09-19	ZTS	145.88	3.9	194.5	6.35
2025-09-22	ZTS	144.65	3.9	194.0	6.35
2025-09-23	ZTS	142.60	3.9	174.1	6.35
2025-09-24	ZTS	141.71	3.9	201.4	6.35
2025-09-25	ZTS	141.13	3.9	210.0	6.35
2025-09-26	ZTS	143.50	3.9	281.3	6.35
2025-09-29	ZTS	143.05	3.9	212.3	6.35
2025-09-30	ZTS	146.40	3.9	304.1	6.35
2025-10-01	ZTS	146.95	3.9	238.2	6.35
2025-10-02	ZTS	146.44	3.9	211.2	6.35
2025-10-03	ZTS	146.46	3.9	222.5	6.35
2025-10-06	ZTS	145.39	4.1	197.1	6.36
2025-10-07	ZTS	142.84	4.1	163.1	6.36
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-08	ZTS	-0.29	0.48	1.49
2025-09-09	ZTS	-0.27	0.48	1.49
2025-09-10	ZTS	-0.27	0.48	1.49
2025-09-11	ZTS	-0.27	0.48	1.75
2025-09-12	ZTS	-0.08	0.48	1.75
2025-09-15	ZTS	-0.08	0.45	1.75
2025-09-16	ZTS	-0.08	0.45	1.75
2025-09-17	ZTS	-0.08	0.45	1.75
2025-09-18	ZTS	-0.08	0.45	1.75
2025-09-19	ZTS	-0.08	0.45	1.75
2025-09-22	ZTS	-0.08	0.46	1.75
2025-09-23	ZTS	-0.09	0.46	1.75
2025-09-24	ZTS	-0.09	0.46	1.75
2025-09-25	ZTS	-0.09	0.46	2.08
2025-09-26	ZTS	-0.09	0.46	2.08
2025-09-29	ZTS	-0.09	0.46	2.08
2025-09-30	ZTS	-0.09	0.46	2.08
2025-10-01	ZTS	-0.09	0.46	2.08
2025-10-02	ZTS	-0.09	0.46	2.08
2025-10-03	ZTS	-0.09	0.46	2.08
2025-10-06	ZTS	-0.09	0.37	2.08
2025-10-07	ZTS	-0.08	0.37	2.08
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

1.61

Avg. EPS Est. Current Quarter

1.64

Avg. EPS Est. Next Quarter

1.48

Insider Transactions

-0.08

Institutional Transactions

0.37

Beta

0.9

Average Sales Estimate Current Quarter

2421

Average Sales Estimate Next Quarter

2425

Fair Value

150.16

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

42.7

Max Drawdown 5-Year %

-46.5

Target Price

194.21

P/E

24.56

Forward P/E

20.64

PEG

2.87

P/S

6.74

P/B

12.74

P/Free Cash Flow

28.51

EPS

5.81

Average EPS Est. Cur. Y

6.36

EPS Next Y. (Est.)

6.88

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

27.83

Relative Volume

0.89

Return on Equity vs Sector %

27.3

Return on Equity vs Industry %

44.5

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

163.1

Zoetis Inc.

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 13800

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1950 and is headquartered in Parsippany, New Jersey.

stock quote shares ZTS – Zoetis Inc. Stock Price stock today

news today ZTS – Zoetis Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ZTS – Zoetis Inc. yahoo finance google finance

stock history ZTS – Zoetis Inc. invest stock market

stock prices ZTS premarket after hours

ticker ZTS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ZTS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y